Alzamend Neuro starts Phase 2 trial of AL001 with novel coil tech to test improved lithium delivery in the brain for multiple ...

QMENTA's AI platform will streamline imaging analysis and ensure regulatory compliance during all trials. Alzamend to launch five Phase 2 trials of AL001, including PTSD and bipolar disorder ...

A novel cannula delivery system has been developed to enhance multiphoton microscopy by enabling the direct administration of imaging agents and drugs to the brain, bypassing the blood-brain barrier.

The imaging findings revealed decreases in excitatory neurotransmitters, which are normally increased in bipolar disorder.

In a groundbreaking study in Biological Psychiatry, published by Elsevier, researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents. They demonstrate ...